Literature DB >> 1885462

Effect of increased Hb-O2 affinity on VO2max at constant O2 delivery in dog muscle in situ.

M C Hogan1, D E Bebout, P D Wagner.   

Abstract

We investigated the effect of increasing hemoglobin- (Hb) O2 affinity on muscle maximal O2 uptake (VO2max) while muscle blood flow, [Hb], HbO2 saturation, and thus O2 delivery (muscle blood flow X arterial O2 content) to the working muscle were kept unchanged from control. VO2max was measured in isolated in situ canine gastrocnemius working maximally (isometric tetanic contractions). The muscles were pump perfused, in alternating order, with either normal blood [O2 half-saturation pressure of hemoglobin (P50) = 32.1 +/- 0.5 (SE) Torr] or blood from dogs that had been fed sodium cyanate (150 mg.kg-1.day-1) for 3-4 wk (P50 = 23.2 +/- 0.9). In both conditions (n = 8) arterial PO2 was set at approximately 200 Torr to fully saturate arterial blood, which thereby produced the same arterial O2 contents, and muscle blood flow was set at 106 ml.100 g-1.min-1, so that O2 delivery in both conditions was the same. VO2max was 11.8 +/- 1.0 ml.min-1.100 g-1 when perfused with the normal blood (control) and was reduced by 17% to 9.8 +/- 0.7 ml.min-1.100 g-1 when perfused with the low-P50 blood (P less than 0.01). Mean muscle effluent venous PO2 was also significantly less (26 +/- 3 vs. 30 +/- 2 Torr; P less than 0.01) in the low-P50 condition, as was an estimate of the capillary driving pressure for O2 diffusion, the mean capillary PO2 (45 +/- 3 vs. 51 +/- 2 Torr). However, the estimated muscle O2 diffusing capacity was not different between conditions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885462     DOI: 10.1152/jappl.1991.70.6.2656

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

1.  Rebuttal from Peter D. Wagner.

Authors:  Peter D Wagner
Journal:  J Physiol       Date:  2015-09-01       Impact factor: 5.182

2.  CrossTalk opposing view: Diffusion limitation of O2 from microvessels into muscle does not contribute to the limitation of V̇O2 max.

Authors:  Carsten Lundby; David Montero
Journal:  J Physiol       Date:  2015-09-01       Impact factor: 5.182

3.  CrossTalk proposal: Diffusion limitation of O2 from microvessels into muscle does contribute to the limitation of V̇O2 max.

Authors:  Peter D Wagner
Journal:  J Physiol       Date:  2015-09-01       Impact factor: 5.182

4.  Human skeletal muscle intracellular oxygenation: the impact of ambient oxygen availability.

Authors:  Russell S Richardson; Sandrine Duteil; Claire Wary; D Walter Wray; Jan Hoff; Pierre G Carlier
Journal:  J Physiol       Date:  2006-01-05       Impact factor: 5.182

5.  Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors.

Authors:  Fabio Esposito; Odile Mathieu-Costello; Ralph Shabetai; Peter D Wagner; Russell S Richardson
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

Review 6.  Maximal oxygen consumption in healthy humans: theories and facts.

Authors:  Guido Ferretti
Journal:  Eur J Appl Physiol       Date:  2014-07-02       Impact factor: 3.078

7.  Modelling the relationships between haemoglobin oxygen affinity and the oxygen cascade in humans.

Authors:  John R A Shepherd; Paolo B Dominelli; Tuhin K Roy; Timothy W Secomb; James D Hoyer; Jennifer L Oliveira; Michael J Joyner
Journal:  J Physiol       Date:  2019-07-25       Impact factor: 5.182

8.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

9.  Operation Everest II.

Authors:  Peter D Wagner
Journal:  High Alt Med Biol       Date:  2010       Impact factor: 1.981

10.  Modulation of perfusion and oxygenation by red blood cell oxygen affinity during acute anemia.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-20       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.